Inventor · disambiguated record
Mark Moody
Also filed as: MOODY MARK · MOODY MARK D · MOODY MARK DAVID
10 granted patents·9 pending applications·76 citations·filing 1989–2023
88Inventor score
Files withCOMERA LIFE SCIENCES INC6REFORM BIOLOGICS LLC4NEWIMMUNE II LLC2ALLIED SIGNAL INC1BOS FABRICATION ENG SERVICES PTY LTD1
Top patents by PatentIndex Score
19 records- 0197US9605051B2Viscosity-reducing excipient compounds for protein formulationsREFORM BIOLOGICS LLC·Filed 2015·Granted Mar 28, 2017·37 cites·12 claims
- 0296US9867881B2Viscosity-reducing excipient compounds for protein formulationsREFORM BIOLOGICS LLC·Filed 2017·Granted Jan 16, 2018·14 cites·17 claims
- 0394US10478498B2Excipient compounds for biopolymer formulationsREFORM BIOLOGICS LLC·Filed 2016·Granted Nov 19, 2019·9 cites·10 claims
- 0491US11660343B2Viscosity-reducing excipient compounds for protein formulationsCOMERA LIFE SCIENCES INC·Filed 2019·Granted May 30, 2023·3 cites·17 claims
- 0587US11357857B2Excipient compounds for protein processingCOMERA LIFE SCIENCES INC·Filed 2018·Granted Jun 14, 2022·3 cites·21 claims
- 0686US11806399B2Excipient compounds for biopolymer formulationsCOMERA LIFE SCIENCES INC·Filed 2021·Granted Nov 7, 2023·1 cites·25 claims
- 0783US2023381318A1Viscosity-reducing excipient compounds for protein formulationsCOMERA LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
- 0882US11672865B2Viscosity-reducing excipient compounds for protein formulationsCOMERA LIFE SCIENCES INC·Filed 2022·Granted Jun 13, 2023·0 cites·21 claims
- 0974US8877687B2Assays for anti-drug antibodies in the presence of abundant endogenous protein counterpart of the drugSONG SAM SHENGHUA·Filed 2011·Granted Nov 4, 2014·6 cites·8 claims
- 1067US2025049915A2Nanoparticulate formulationNEWIMMUNE II LLC·Filed 2022·Application pending·0 cites
- 1167US2024335383A1Nanoparticulate formulationNEWIMMUNE II LLC·Filed 2022·Application pending·0 cites
- 1266US2023065872A1Excipient compounds for protein processingCOMERA LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1365US2021379185A1Excipient compounds for protein processingREFORM BIOLOGICS LLC·Filed 2021·Application pending·0 cites
- 1462US2016074515A1Viscosity-reducing excipient compounds for protein formulationsREFORM BIOLOG LLC·Filed 2015·Application pending·0 cites
- 1549US2025084945A1Test capBOS FABRICATION ENG SERVICES PTY LTD·Filed 2022·Application pending·0 cites
- 1646US2005020542A1Method of modulating sodium ion absorption in epithelial cellsFiled 2002·Application pending·0 cites
- 1739US2010234277A1Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic diseaseMOODY MARK·Filed 2007·Application pending·0 cites
- 1832US7453006B2Inositol derivatives for increasing chloride secretion and inhibiting inflammationINOLOGIC INC·Filed 2001·Granted Nov 18, 2008·0 cites·3 claims
- 1931US5012902ACaliper and retaining pin spacerALLIED SIGNAL INC·Filed 1989·Granted May 7, 1991·3 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Mark Moody files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →